The closest to a C1 estimate is the January 2022 scoping study estimate of $558/t for HPMSM (100kt). I'm expecting there will be an update to this estimate in the Feasibility study that remains on-track to be delivered in December. Even if the ore purchase price was 10 or 20% more expensive than the $159 estimate, it is not going to destroy the economics of HP MSM.
Manganese X is another company looking to develop a HPMSM project. Two slides from their August 2022 presentation are included below. On this estimate there's a potential market size >1,000kt by 2027. This is a lot higher than E25's Scoping study estimate showing circa 400kt by 2028.
Manganese X had a June 2022 PEA with the following price estimate. This indicates that even during the 2020 low-point where Lithium demand/supply dynamics caused the lithium price to crash, HPMSM remained around $900/t (reading from the graph). The price chart forecast may be bullish beyond 2025 but E25's of $1,950 is aligned to CPM shorter-term forecast estimates and well below their long-term forecasts.
- Forums
- ASX - By Stock
- Ann: HPMSM Feasibility Study Update
E25
element 25 limited
Add to My Watchlist
0.00%
!
22.5¢

The closest to a C1 estimate is the January 2022 scoping study...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $21.94K | 100.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 62609 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 0.215 |
3 | 28857 | 0.210 |
2 | 8107 | 0.205 |
7 | 59405 | 0.200 |
3 | 13077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 62609 | 2 |
0.230 | 72958 | 1 |
0.235 | 24800 | 2 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online